Related Experiment Video
Updated: Jun 14, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Structural and molecular determinants of glutamate transporter allosteric modulators
Katelyn L Reeb1, Satyaki Saha2, Xiaowei Bogetti3
1Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
Molecular Pharmacology
|June 12, 2026
Summary
We identified key amino acids and subdomains that control the activity of excitatory amino acid transporters (EAATs). This discovery advances the development of allosteric modulators for neurological disorders involving glutamate dysregulation.
Area of Science:
- Neuroscience
- Pharmacology
- Structural Biology
Background:
- Excitatory amino acid transporters (EAATs) regulate central nervous system glutamate levels, crucial for neurological health.
- Dysfunctional glutamatergic signaling is linked to various neurological diseases.
Purpose of the Study:
- To characterize allosteric modulators of EAATs and identify their binding sites and mechanisms.
- To understand the structural basis for selective EAAT modulation.
Main Methods:
- Molecular modeling and docking studies.
- Site-directed mutagenesis and functional assays.
- Pharmacological characterization of EAAT modulators.
Main Results:
- Identified allosteric binding sites for EAAT modulators in transmembrane domains.
- Discovered ten key amino acid residues in EAAT2 that confer selective positive allosteric modulator (PAM) activity when transferred to EAAT1.
- Confirmed that modulators do not bind to the orthosteric glutamate site.
Conclusions:
- Elucidated the structural determinants of selective EAAT allosteric modulation.
- This work provides a foundation for developing novel EAAT-targeting therapies for neurological conditions.
- Identified specific residues crucial for selective PAM function, guiding future drug design.
Related Concept Videos
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...